Veterinary Oncology Market Analysis Highlighting Future Prospects in 2034
According to Fortune Business Insights, the global veterinary oncology market size was valued at USD 2.90 billion in 2025 and is projected to grow from USD 3.15 billion in 2026 to USD 7.11 billion by 2034, exhibiting a CAGR of 10.70% during the forecast period. North America dominated the veterinary oncology market with a market share of 47.58% in 2025.
The veterinary oncology market is gaining importance as pet ownership increases and companion animals receive more advanced medical care. Cancer is among the major health concerns affecting companion animals, particularly as pets live longer due to improvements in nutrition, preventive healthcare, diagnostics, and veterinary services. Greater awareness among pet owners regarding cancer symptoms and treatment options is encouraging earlier veterinary consultations and diagnosis. Veterinary clinics and specialty hospitals are increasingly adopting advanced diagnostic and therapeutic approaches to improve outcomes for animals affected by cancer. These developments include imaging technologies, biopsy procedures, histopathology, immunohistochemistry, chemotherapy, radiation therapy, targeted therapies, and surgical oncology. The veterinary oncology market is also benefiting from increasing expenditure on companion animal healthcare. Pet owners are increasingly willing to pursue specialized treatments and diagnostic procedures for their animals, particularly in developed markets. Veterinary hospitals are expanding oncology services, while pharmaceutical companies are developing therapies specifically designed for animal patients. Growing research into animal cancers is also improving understanding of tumor biology and supporting the development of new therapeutic approaches. Increasing collaboration between veterinary institutions, pharmaceutical companies, diagnostic laboratories, and research organizations is expected to strengthen the availability of specialized oncology care. The veterinary oncology market therefore represents an important segment of the broader animal healthcare industry, supported by advances in diagnosis, treatment, and veterinary clinical infrastructure.
Continue reading for more details:
https://www.fortunebusinessinsights.com/veterinary-oncology-market-117236
Market Segmentation
The veterinary oncology market is segmented by animal type, cancer type, treatment, distribution channel, and region. Based on animal type, the market includes dogs, cats, and other animals. Dogs represent a major segment because canine cancer is frequently diagnosed in veterinary practice and pet owners increasingly seek specialized treatment. Cats also represent an important segment as awareness of feline cancer and access to specialized veterinary services continue to improve.
Based on cancer type, the veterinary oncology market is categorized into lymphoma, mast cell tumors, mammary tumors, soft tissue sarcomas, osteosarcoma, and other cancers. Lymphoma represents a significant cancer category because it affects multiple animal species and can require specialized diagnostic and therapeutic management. Mast cell tumors are also important, particularly in dogs, creating demand for veterinary oncology diagnostics, surgery, and drug-based treatment.
By treatment, the market includes surgery, chemotherapy, radiation therapy, immunotherapy, targeted therapy, and other treatment approaches. Surgery remains an important treatment option for localized tumors and is frequently used as part of comprehensive cancer management. Chemotherapy is widely utilized for cancers that require systemic treatment. Radiation therapy is gaining attention for managing tumors that cannot be completely removed through surgery. Immunotherapy and targeted therapy are emerging areas of veterinary oncology as researchers seek more precise treatment approaches with improved therapeutic outcomes.
Based on distribution channel, the veterinary oncology market is divided into veterinary hospitals and clinics, specialty veterinary centers, veterinary pharmacies, and other channels. Veterinary hospitals and clinics account for a significant share because diagnosis, treatment planning, surgery, chemotherapy, and follow-up care are generally delivered through veterinary healthcare facilities. Specialty veterinary centers are also becoming increasingly important as they provide access to veterinary oncologists, advanced diagnostic equipment, radiation therapy, and specialized treatment programs.
Key Players
- Zoetis Inc.
- Elanco Animal Health Incorporated
- Merck Animal Health
- Boehringer Ingelheim International GmbH
- IDEXX Laboratories, Inc.
- Virbac
- PetCure Oncology
- Varian Medical Systems
- Dechra Pharmaceuticals Limited
- Karyopharm Therapeutics Inc.
Market Growth
The veterinary oncology market is experiencing growth due to increasing cancer prevalence among companion animals, rising pet healthcare expenditure, and greater awareness of specialized veterinary treatment. Pet owners increasingly consider companion animals as family members and are more willing to pursue advanced diagnostic procedures and treatment options when cancer is suspected. This humanization of pets is encouraging veterinary hospitals to expand specialized services and invest in advanced oncology infrastructure.
Technological advancements are another major factor supporting the veterinary oncology market. Improvements in diagnostic imaging, pathology, molecular diagnostics, and laboratory testing enable veterinarians to identify tumors more accurately and determine appropriate treatment strategies. Advanced imaging technologies can help veterinarians assess tumor location and progression, while histopathological and molecular testing supports more precise cancer classification. These developments are improving treatment planning and strengthening demand for specialized veterinary oncology services.
The increasing availability of veterinary cancer drugs is also contributing to market development. Pharmaceutical companies are investing in therapies designed to address specific cancers in animals, while research institutions are exploring immunotherapy, targeted therapy, and other innovative approaches. Comparative oncology research is providing additional opportunities because naturally occurring cancers in companion animals can offer valuable insights into cancer biology and therapeutic responses. The expansion of veterinary specialty hospitals and referral centers is further improving access to oncology services. As veterinary professionals receive greater access to specialized training and advanced equipment, more complex cancer cases can be diagnosed and treated within dedicated veterinary facilities.
Restraining Factors
Despite the positive outlook, several factors can restrict the expansion of the veterinary oncology market. The high cost associated with advanced cancer diagnostics and treatment can limit access, particularly for pet owners with restricted financial resources. Veterinary oncology may involve multiple diagnostic procedures, specialized consultations, surgery, medication, radiation therapy, and long-term monitoring, which can create a substantial financial burden.
Limited availability of veterinary oncologists and specialized cancer treatment centers can also restrict access to advanced care in certain regions. Veterinary oncology requires specialized knowledge, equipment, and infrastructure, and the concentration of these resources in major urban areas can make treatment less accessible to animals in smaller communities. In addition, limited awareness among some pet owners about cancer symptoms and available treatment options may result in delayed diagnosis. Concerns regarding treatment outcomes, animal comfort, and the willingness of owners to pursue intensive treatment can also influence decisions. Regulatory complexities surrounding veterinary medicines and the development of animal-specific oncology therapies may further affect the introduction of innovative treatments. Addressing affordability, accessibility, professional training, and awareness will therefore remain important for the continued development of the veterinary oncology market.
Regional Analysis
North America represents the leading region in the veterinary oncology market, supported by high pet ownership, strong expenditure on companion animal healthcare, advanced veterinary infrastructure, and broad availability of specialized oncology services. Veterinary hospitals and specialty centers across the region increasingly provide advanced cancer diagnostics, surgery, chemotherapy, radiation therapy, and other treatment options. High awareness among pet owners and increasing demand for sophisticated veterinary care are also supporting regional market development.
Europe is witnessing increasing demand for veterinary oncology services due to rising awareness of companion animal health and the availability of advanced veterinary healthcare infrastructure. Veterinary clinics and specialty hospitals are adopting sophisticated diagnostic technologies and treatment approaches to manage cancer cases. Growth in pet ownership and increasing willingness among owners to pursue specialized medical care are also supporting the regional veterinary oncology market.
Asia Pacific is emerging as an important market as pet ownership expands and veterinary healthcare infrastructure improves. Increasing urbanization, rising disposable incomes, greater awareness of companion animal diseases, and growing investment in veterinary hospitals are contributing to the adoption of advanced cancer diagnostics and treatments. Veterinary professionals are also gaining greater access to specialized training and modern clinical technologies.
Latin America is experiencing gradual growth as veterinary healthcare services expand and awareness of companion animal cancer increases. Improvements in veterinary infrastructure and increasing demand for specialized treatment are creating opportunities for oncology service providers and pharmaceutical companies. The Middle East & Africa region is also expected to experience increasing adoption of veterinary oncology services as veterinary healthcare facilities improve and awareness of advanced animal treatments increases. The expansion of specialized clinics and greater availability of diagnostic services are expected to support the development of the veterinary oncology market across the region.
Comments